A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis, Oral MS Medications

Information provided by: Cherie C. Binns RN BS MSCN
From the MS Association of America’s Motivator Summer/Fall 2010 issue
Based on the positive response to the “MS Research Updates” published from 2007 through 2009 in New England Journal of Medicine, this year’s article incorporates new information about the eight approved disease-modifying therapies (DMTs), as well as numerous experimental drugs currently under investigation for the treatment of MS. Highlights and recent study results are provided for each drug. This is not a complete list and not all information is included. Initial findings should be considered as preliminary, as additional studies and/or evaluations may be needed.

CLICK HERE to read this very well written / complete article on what we ( the MS patients), need to know to be kept informed and up-to-date.

***********************************************************
Providing You with ‘MS Views and News’is what we do
Keep Informed and uptodate with information concerning
 Multiple Sclerosis when registered at
****************************************************************



Disclaimer:  ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews